• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSM FLOW DIVERTER Back to Search Results
Model Number NOT REPORTED
Device Problem Migration or Expulsion of Device (1395)
Patient Problem No Information (3190)
Event Type  Injury  
Event Description
Information received from the article: boddu sr, tong fc, dehkharghani s, et al.Contrast-enhanced time-resolved mra for follow-up of intracranial aneurysms treated with the pipeline embolization device.Ajnr.2014 nov; 2112-2118.During a period of two years, 26 patients had intracranial aneurysms that were treated with a total of 37 pipeline embolization devices.A 3d-tof mra (magnetic resonance imaging), contrast-enhanced time-resolved mra, and dsa (digital subtraction angiography) were used in the initial follow-up of the patients.All patients underwent dsa an average of 0 days (range, 0¿68) after mra.Studies were evaluated for aneurysm occlusion, quality of visualization of the reconstructed artery, and measurable luminal diameter of the pipeline embolization device, with dsa used as the reference standard.One patient was suffering from a right cavernous carotid aneurysm.The patient underwent pipeline embolization treatment and post procedural images showed stasis within the aneurysm.At 6-month follow-up, images showed complete opacification of the aneurysm with no stasis or thrombus.Distal migration of the pipeline was diagnosed on ce-tr mra and confirmed on dsa; the aneurysm neck reopened with refilling of the entire aneurysm as a result of the migration.No other information regarding patient condition was presented in the article.
 
Manufacturer Narrative
The lot history record review was not possible as the lot number was not reported.The device will not be returned for analysis as it was implanted in the patient; therefore, the event cause could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PIPELINE EMBOLIZATION DEVICE
Type of Device
INTRACRANIAL ANEURYSM FLOW DIVERTER
Manufacturer (Section D)
COVIDIEN
9775 toledo way
irvine CA 92618
Manufacturer (Section G)
COVIDIEN (IRVINE)
9775 toledo way
irvine CA 92618
Manufacturer Contact
9775 toledo way
irvine, CA 92618
9496801558
MDR Report Key4391141
MDR Text Key14879374
Report Number2029214-2015-00004
Device Sequence Number1
Product Code OUT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100018.S004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature
Reporter Occupation Physician
Type of Report Initial
Report Date 12/08/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT REPORTED
Device Lot NumberNOT REPORTED
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/08/2014
Initial Date FDA Received01/07/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Disability;
Patient Age56 YR
-
-